| Literature DB >> 26504494 |
Jolien S van Campen1, Floor E Jansen2, Nienke J Kleinrensink2, Marian Joëls3, Kees Pj Braun2, Hilgo Bruining4.
Abstract
BACKGROUND: Altered sensory sensitivity is generally linked to seizure-susceptibility in childhood epilepsy but may also be associated to the highly prevalent problems in behavioral adaptation. This association is further suggested by the frequent overlap of childhood epilepsy with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), conditions in which altered behavioral responses to sensory stimuli have been firmly established. A continuum of sensory processing defects due to imbalanced neuronal inhibition and excitation across these disorders has been hypothesizedthat may lead to common symptoms of inadequate modulation of behavioral responses to sensory stimuli. Here, we investigated the prevalence of sensory modulation disorders among children with epilepsy and their relation with symptomatology of neurodevelopmental disorders.Entities:
Keywords: Epilepsy; Excitation; Seizures; Sensory modulation
Year: 2015 PMID: 26504494 PMCID: PMC4620742 DOI: 10.1186/s11689-015-9130-9
Source DB: PubMed Journal: J Neurodev Disord ISSN: 1866-1947 Impact factor: 4.025
Fig. 1Sensory modulation quadrants: relationship between sensory threshold and self-regulation [22, 36, 37]. Figure adapted from [60]
Children excluded after receiving questionnaires
| Exclusion criteria | Number of children excluded |
|---|---|
| Developmental age <2 years | 41 |
| Last seizure >12 months ago | 9 |
| Caregivers cannot recognize epileptic seizures | 5 |
| No understanding of Dutch language | 5 |
| Age at completion of questionnaires >17 years | 3 |
| Seizure freedom after epilepsy surgery | 2 |
| Death | 1 |
| Total | 66 |
Characteristics of responders and non-responders
| Characteristics | Responders ( | Non-responders ( |
|
|---|---|---|---|
| General | |||
| Gender, % male | 51 | 65 | 0.01 |
| Age, median (range) | 9.6 (4.1–16.7) yr | 10.0 (4.1–16.6) yr | 0.45 |
| Epilepsy | |||
| Seizure frequency (chart-based), median (range) | 1/wk (0/3 mo–20/h) | 1/wk (0/3 mo–12/h) | 0.64 |
| Seizure frequency (questionnaire-based), median (range) | 2/wk (0/3 mo–15/day) | - | - |
| Etiology (chart-based), % | 0.78 | ||
| Genetic | 11 | 13 | |
| Structural | 48 | 42 | |
| Metabolic | 4 | 5 | |
| Unknown | 36 | 39 | |
| Seizure classification (chart-based), % | |||
| Focal | 44 | 45 | 0.91 |
| Generalized | 51 | 59 | 0.17 |
| Epileptic spasms | 2 | 1 | 0.62 |
| Unknown | 18 | 16 | 0.76 |
| Localization (chart-based), distribution, % | 0.06 | ||
| Focal | 57 | 48 | |
| Multifocal | 22 | 24 | |
| Generalized | 18 | 19 | |
| Unknown | 3 | 9 | |
| Localization (chart-based), lobe, % | |||
| Frontal | 18 | 5 | <0.001 |
| Temporal | 20 | 9 | 0.006 |
| Parietal | 15 | 8 | 0.16 |
| Occipital | 6 | 4 | 0.60 |
| Unknown | 15 | 25 | 0.07 |
| Anti-epileptic treatment (questionnaire-based), % | |||
| AED | 98 | - | - |
| GABA enhancers | 50 | - | |
| Glutamate receptor antagonists | 8 | - | |
| Sodium channel blockers | 60 | - | |
| Calcium channel blockers | 25 | - | |
| Other | 32 | - | |
| Vagal nerve stimulator | 6 | - | - |
| Ketogenic diet | 6 | - | - |
| Developmental | |||
| Intelligence | |||
| Intellectual disability (chart-based), % | 42 | 47 | 0.36 |
| IQ or DQ (test-based), median (range) | 80 (23–148) | - | - |
| ADHD | |||
| Diagnosis (chart-based), % | 1 | 5 | 0.10 |
| Symptoms (SDQ questionnaire-based), % | |||
| Abnormal | 38 | - | - |
| Borderline | 14 | - | |
| Normal | 48 | - | |
| ASD | |||
| Diagnosis (chart-based), % | 12 | 11 | 0.86 |
| Symptoms (SRS questionnaire-based), % | |||
| Severe ASD symptoms | 12 | - | - |
| ASD symptoms | 11 | - | |
| Mild/moderate ASD symptoms | 33 | - | |
| No ASD symptoms | 44 | - |
n number of patients, AED anti-epileptic drugs, intellectual disability IQ or DQ <70, IQ intelligence quotient, DQ development quotient, ASD autism spectrum disorder, SRS Social Responsiveness Scale, ADHD attention deficit hyperactivity disorder, SDQ Strengths and Difficulties Questionnaire, h hour, wk week, mo month, yr year, - not applicable
Fig. 2Sensory modulation in subgroups of children with epilepsy. a Percentage of sensory modulation disorders. b Sensory Profile quadrant scores. n number of patients, ASD autism spectrum disorder based on questionnaire, ADHD attention deficit hyperactivity disorder based on questionnaire. Values represent mean Z-scores and 95 % confidence interval, based on age-specific norms [22, 36]
Fig. 3Sensory modulation scores in children with epilepsy. Sensory Profile quadrant scores of all children 4–17 years of age (n = 158) and subsection scores of children 4–12 years of age (n = 120). Values represent mean Z-scores (based on age-specific norms [22, 36]) and 95 % CI, *p value <0.001 compared with the reference population
Relation between patient characteristics and sensory modulation
| Characteristics | Analyses (F) | Post-hoc tests (beta) | ||||
|---|---|---|---|---|---|---|
| Univar | Multivara | Poor registration | Sensory seeking | Sensory sensitivity | Sensory avoiding | |
| Gender, male | 1.8 | - | - | - | - | - |
| Age | 24.8*** | 24.6*** | −0.41*** | −0.41*** | −0.13 | −0.46*** |
| Intelligence (IQ or DQ) | 14.2*** | 5.6*** | −0.16 | −0.21* | −0.12 | 0.15 |
| Age at onset of epilepsy | 8.7*** | ns | - | - | - | - |
| Seizure frequency | 2.0^ | ns | - | - | - | - |
| Etiology | ||||||
| Genetic | 0.6 | - | - | - | - | - |
| Structural | 1.3 | - | - | - | - | - |
| Metabolic | 1.0 | - | - | - | - | - |
| Unknown | ref | - | - | - | - | - |
| Distribution, hemisphere | ||||||
| Left | 3.9** | ns | - | - | - | - |
| Right | 2.1* | ns | - | - | - | - |
| Both | ref | ref | - | - | - | - |
| Distribution, lobe | ||||||
| Frontal | 0.7 | - | - | - | - | - |
| Temporal | 1.5 | - | - | - | - | - |
| Parietal | 0.1 | - | - | - | - | - |
| Occipital | 1.3 | - | - | - | - | - |
| Number of AEDs | 4.6** | ns | - | - | - | - |
| AED-type | ||||||
| GABA-enhancer | 3.3* | ns | - | - | - | - |
| Glutamate antagonist | 1.9^ | ns | - | - | - | - |
| Sodium channel blocker | 0.5 | - | - | - | - | - |
| Calcium channel blocker | 0.4 | - | - | - | - | - |
| ASD symptoms (SRS) | 13.9*** | 6.3*** | 0.29** | 0.01 | 0.22* | 0.45*** |
| ADHD symptoms (SDQ) | 18.3*** | 7.3*** | 0.10 | 0.33*** | 0.24** | −0.06 |
Univar multivariate univariable regression analysis, multivar multivariate multivariable regression analysis, post-hoc tests univariate multiple regression analyses per quadrant Bonferroni-corrected for multiple comparison, IQ intelligence quotient, DQ development quotient, AED anti-epileptic drug, GABA γ-aminobutyric acid, - not included in model, ns not significant
p values: ^<0.1 (only indicated for multivariate univariable regression analysis), *<0.05, **<0.01, ***<0.001
aAdjusted R 2 poor registration = 0.453, sensory seeking = 0.463, sensory sensitivity = 0.269, sensory avoiding = 0.340